Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Apeiron Investment Group

Investor type Family Investment Office
Founders Christian Angermayer

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 31
Average round size
info
The average size of a deal this fund participated in
$48M
Portfolio companies 19
Rounds per year 3.10
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.39
Exits 5
Key employees 3
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Life Science
  • Health Care
  • Therapeutics
  • Biopharma
Summary

The leading representative office of defined VC is situated in the Sliema. The company was established in Europe in Malta.

The top activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The average startup value when the investment from Apeiron Investment Group is 10-50 millions dollars. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year.

We can highlight the next thriving fund investment areas, such as E-Commerce, Finance. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Springlane, Juvenescence, Zenhomes For fund there is no match between the country of its foundation and the country of its the most frequent investments - Germany.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Apeiron Investment Group, startups are often financed by Heliad Equity Partners, HV Holtzbrinck Ventures, TEV | Tengelmann Ventures. The meaningful sponsors for the fund in investment in the same round are Christian Angermayer, main incubator, Valar Ventures. In the next rounds fund is usually obtained by Longevity Vision Fund, IPGL, Grok Ventures.

The current fund was established by Christian Angermayer.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Apeiron Investment Group:
Typical Co-investors
Apeiron Investment Group is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Apeiron Investment Group:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Malta
Funds with similar focus located in Malta:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Alto Neuroscience

Artificial Intelligence
Biopharma
Neuroscience
$35M25 Oct 2022 Los Altos, California, United States

Rejuveron Life Sciences

Biotechnology
Health Care
Medical
17 Mar 2022 Zurich, Switzerland

Peek

Internet
Marketplace
Mobile
SaaS
Tourism
Travel
$80M23 Nov 2021 San Francisco, California, United States

Mynaric

Aerospace
Communication Hardware
Internet
Satellite Communication
Telecommunications
$75M12 Nov 2021 Germany, Bavaria, Germany

Cambrian Biopharma

Biopharma
Biotechnology
Life Science
$100M26 Oct 2021 New York, New York, United States

Jasper Therapeutics

Biotechnology
Health Care
Pharmaceutical
$100M27 Sep 2021 Latvia, Courland, Latvia

Upmin

$4M06 Sep 2021 -

Olsam Group

Consumer Goods
E-Commerce
$164M01 Sep 2021 London, England, United Kingdom

Isar Aerospace

Aerospace
Information Technology
Space Travel
$75M28 Jul 2021 Munich, Bavaria, Germany
News
Olsam Group Raises $165M in Series A Equity and Debt Funding Round

– Olsam Group from London buys and scales e-commerce businesses.
– The company raised $165m in Series A equity and debt funding round.
– The equity funding was led by Christian Angermayer’s Apeiron Investment Group and Elevat3 Capital.
– Debt financing was led by North Wall Capital.

atai Life Sciences Announces the Closing of its $157 Million Series D Financing Round

– atai Life Sciences announced the closing of its $157m Series D financing round.
– The round was led by Apeiron Investment Group and joined by Woodline Partners LP.
– The proceeds from this financing will support the expansion and development of the Company’s diverse drug candidate pipeline and enabling technologies.
– In addition, the financing will provide the necessary runway to continue advancing its current clinical developments, as well as scale its experienced team in order to continue delivering key milestones.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Apeiron Investment Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: